Logo
x

Search

Subscribe Now

All Posts by Date

HanAll's Licensed Partner Entered into an Exclusive Sublicense Agreement with CSPC NBP Pharma for Batoclimab

HanAll's Licensed Partner Entered into an Exclusive Sublicense Agreement with CSPC NBP Pharma for Batoclimab

  • October 11, 2022
Regeneron Presents P-III Trial Results of Dupixent (dupilumab) for Eosinophilic Esophagitis in Children Aged 1 to 11 Years at UEG 2022

Regeneron Presents P-III Trial Results of Dupixent (dupilumab) for Eosinophilic Esophagitis in Children Aged 1 to 11 Years at UEG...

  • October 11, 2022
JW Therapeutics Receives the NMPA’s Approval for Carteyva (relmacabtagene autoleucel) sNDA to Treat Relapsed or Refractory Follicular Lymphoma

JW Therapeutics Receives the NMPA’s Approval for Carteyva (relmacabtagene autoleucel) sNDA to Treat Relapsed or Refractory Follicu...

  • October 11, 2022
Brainomix Collaborated with UK Government-Funded NCIMI for AI-Powered Technology in Lung Cancer

Brainomix Collaborated with UK Government-Funded NCIMI for AI-Powered Technology in Lung Cancer

  • October 11, 2022
Merck Reports P-III (STELLAR) Trial Results of Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Merck Reports P-III (STELLAR) Trial Results of Sotatercept for the Treatment of Pulmonary Arterial Hypertension

  • October 11, 2022
Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

  • October 11, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.